This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (5) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Steup-Beekman, G. Articles by Huizinga, T. Search for Related Content PubMed PubMed Citation Articles by Steup-Beekman, G. Articles by Huizinga, T. Pubmed/NCBI databases Medline Plus Health Information Family Issues Lupus Social Bookmarking                         What's this?

Anti-NMDA receptor autoantibodies in patients with systemic lupus erythematosus and their first-degree relatives

Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands, g.m.steup-beekman{at}lumc.nl

Sca Steens

Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands

MA van Buchem

Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands

Twj Huizinga

Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands

The objective of this study is to investigate the presence of autoantibodies cross-reacting with the NR2 subunit of the N-methyl-d-aspartate (NMDA) glutamate receptor in plasma samples of patients with systemic lupus erythematosus (SLE), in their healthy first-degree relatives and in healthy unrelated individuals and to determine whether these autoantibodies are specific for lupus patients in general or for the subgroup of SLE patients with neuropsychiatric (NP) manifestations. Plasma samples were collected from 51 lupus patients (19 with and 32 without NP manifestations), 161 first-degree relatives and 55 healthy unrelated controls. Antibodies to a linear peptide of the NR2 subunit of the NMDA receptor were determined by enzyme-linked immunosorbent assay. A significant difference in mean antibody reactivity between SLE patients and healthy unrelated controls (P < 0.01) and between firstdegree relatives and healthy unrelated controls (P < 0.001) was found. No difference was found between lupus patients and their first-degree relatives or between lupus patients with and without NP symptoms. In this study, anti-NMDA receptor autoantibodies show more specificity for lupus patients (but not for selected patients with NP symptoms) and their first-degree relatives than for healthy controls, indicating a familial basis to mount an immune response to this peptide. Lupus (2007) 16, 329—334.

Key Words: autoantibodies • neuropsychiatric • NMDA receptor • systemic lupus erythematosus

Lupus, Vol. 16, No. 5, 329-334 (2007)
DOI: 10.1177/0961203307078224


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				D. Pleasure Diagnostic and Pathogenic Significance of Glutamate Receptor Autoantibodies Arch Neurol, May 1, 2008; 65(5): 589 - 592. [Abstract] [Full Text] [PDF]